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The present work comprises the recombinant synthesis of four metallothioneins (MTs) in metal-unsupplemented cultures and
the characterization of the recovered metal complexes by means of analytical and spectrometric techniques. The four MTs are
two Drosophila (MtnA and MtnB), one yeast (Crs5), and one mouse (mMT1) metallothionein isoforms. These four MTs exhibit
distinct metal binding preferences, from a clear Cu-thionein character to a deﬁnite Zn-thionein nature, respectively. Although in
all cases, the only metal ion present in the puriﬁed complexes is Zn
2+, our results highlight an inherently diﬀerent behaviour of
those two types of MTs, in conditions that would mimic their synthesis in physiological environments. Therefore, intrinsically
diﬀerent roles can be hypothesized for the constitutively-produced MT peptides in the absence of any metal overload, depending
on their Zn- or Cu-thionein character.
1.Introduction
Metallothioneins (MTs) are a superfamily of small proteins,
ubiquitous and probably polyphyletic, which coordinate
heavy-metal ions through metal-thiolate bonds established
bytheirhighlyabundantcysteineresidues[1].Currently,and
since they were ﬁrst reported in 1957 [2], MTs biological
structure and their contribution to a variety of physiological
processes in the most diverse organisms still remain a matter
of debate [3]. Besides their detoxifying properties, MTs
appear to be involved in Zn and Cu homeostasis, while
additionally they seem to participate in a myriad of processes
speciﬁc to each diﬀerent group of organisms considered.
Apo-MTs (also called thioneins) are random coil
polypeptides, which only fold onto a deﬁnite 3D structure
upon metal coordination. This implies that MTs adopt
diﬀerent 3D structures—the main determinant of protein
functionality-depending on the nature and number of the
metal ions that they coordinate in a given metal complex.
This is especially noteworthy because although the level
of expression of MT genes remains generally low in the
absence of metal induction, the possibility exists that some
organisms or tissues accumulate demetalated (without metal
ions) thionein peptides under deﬁnite conditions. In fact,
some years ago, it was claimed that the levels of thionein in
mammalian tissues under physiological conditions could be
signiﬁcantly high enough to harbour important implications
for MT functionality in zinc and redox metabolism [4, 5].
However, native MT synthesis is extremely low unless the
corresponding gene is induced by the presence of a speciﬁc
metal ion or other stress conditions. This, in turn, practically
precludes the puriﬁcation of native apo-forms, produced
in physiological conditions. This serious drawback can be
avoided by means of recombinant synthesis. Remarkably,
although this strategy has been widely used by many
authors to obtain metal-MT complexes of the most diverse
organisms, it has seldom been used to study MT synthesis in
physiological environments in the absence of metal surplus.2 Bioinorganic Chemistry and Applications
Several years ago we set up an E. coli expression system
that enabled the biosynthesis of Zn2+-, Cd2+-, and Cu+-
MT complexes, equivalent to those natively synthesized, of
suﬃcient quantity and purity to permit analytical, spectro-
metric, and spectroscopic characterization, by growing the
corresponding recombinant bacteria in metal supplemented
media [6, 7]. In this work, we have adapted the same
synthesis rationale to study the metal binding abilities of
diﬀerent MTs when produced in bacteria grown in standard
(i.e.,nonmetalsupplementedmedia),particularlyinorderto
determine the features of the zinc-complexes biosynthesized
in these conditions.
To perform this study we selected four Metallothioneins,
belonging to a broad spectrum of organisms: two Drosophila
(MtnA and MtnB), a yeast (Crs5), and a mouse (mMT1)
isoform (Table 1), because they exhibit distinct metal
binding preferences when considered in accordance with
our classiﬁcation as Zn-thionein versus Cu-thionein [8].
We have recently revised this ﬁrst classiﬁcation scheme,
based on two discrete MT groups, and we now propose a
stepwise gradation between extreme Zn-thioneins and Cu-
thioneins that holds a continuum of intermediate forms
in terms of metal binding properties [9]. The results we
include in this paper clearly demonstrate, ﬁrst, that all
MTs are able to some extent to capture and coordinate
Zn2+ ions present in standard (nonsupplemented) bacterial
growth medium (LB). But, secondly, it worths noting how
our results show that the average zinc content and the
precise Zn-MT complexes recovered for a given MT peptide
depend on its situation in our gradate classiﬁcation, in other
words, on its Zn- versus Cu-thionein character. Therefore,
on the one hand this work sheds light on the behaviour
of MT polypeptides when there is no metal surplus in the
surrounding environment; and on the other hand, it adds a
new criterion to support our classiﬁcation of MTs according
to their metal handling abilities.
2. Experimental
2.1. Synthesis of the Recombinant Metal-MT Complexes.
Recombinant syntheses of MTs (primarily as GST-MT
fusions) were achieved through expression of the corre-
sponding cDNAs cloned in pGEX vectors. Construction of
these plasmids is reported in detail in [7] for the mouse
MT1 isoform, [10] for the yeast S. cerevisiae Crs5 MT, and
[11, 12] for the D. melanogaster Mtn (or MtnA) and Mto (or
MtnB) isoforms, respectively. All the metal-MT complexes
analyzed in this work were puriﬁed from 1L cultures of
BL21E.colicellstransformedwiththecorrespondingpGEX-
MT plasmid, grown in standard LB (Luria-Bertani) broth
with 100mg mL−1 ampicillin and no metal supplement,
except for the control condition, when 300μMZ n C l 2 was
added to the LB medium. GST-MT synthesis was induced
with isopropyl-1-thio-β-D-galactopyranoside (IPTG) at a
ﬁnal concentration of 100mM. After 2.5-hour induction,
cells were harvested by centrifugation. To prevent oxidation
of the metal-MT complexes, argon was bubbled in all the
stepsofthepuriﬁcationfollowingcelldisruption.Forprotein
puriﬁcation, cells were resuspended in ice-cold PBS (1.4M
NaCl, 27mM KCl, 101mM Na2HPO4,a n d1 8m MK H 2PO4)
0.5% v/v β-mercaptoethanol, disrupted by sonication, and
centrifuged at 12,000g for 30 minutes. The GST-MT fusions
werepuriﬁedfromtherecoveredsupernatantbygluthatione-
Sepharose 4B (GE Healthcare) batch aﬃnity chromatog-
raphy incubating the mixture with gentle agitation for 60
minutes at room temperature. After three washes in PBS,
and due to the fact that the GST-MT constructs include
a thrombin recognition site, this protease was added (10u
permg of protein) and digestion was carried out overnight
at 23–25◦C. This allowed separation of the GST portion—
which remained bound to the gel matrix—from the MT
moiety (that eluted together with thrombin). Subsequently,
this eluate was concentrated using Centriprep Concentrators
(Amicon) (Millipore, Billerica, MA, USA) with a cut-oﬀ of
3kDa and fractionated using FPLC, through a Superdex-75
column (GE Healthcare) equilibrated with 50mM Tris-HCl,
pH 7.0, and run at 1mL min−1. Fractions were collected,
and analysed for protein content by their absorbance at
254nm. Aliquots of the protein-containing FPLC fractions
were analysed by 15% SDS-PAGE and stained by Coomassie
Blue. MT-containing samples were pooled and stored at
−70◦C until further characterization.
2.2. Inductively Coupled Plasma Atomic Emission Spectroscopy
(ICP-AES). The recombinantly expressed MT complexes
were analyzed for element composition (S, Zn, Cd, and Cu)
by inductively coupled plasma atomic emission spectroscopy
(ICP-AES) on a Polyscan 61E spectrometer (Thermo Jarrell
Ash Corporation, Franklin, MA, USA) at appropriate wave-
lengths (S, 182.040nm; Zn, 213.856nm; Cd, 228.802nm;
Cu, 324.803nm). Samples were prepared either at “conven-
tional” (dilution with 2% HNO3 (v/v)) [13] or at “acidic”
(incubation in 1M HCl at 65◦C for 5 minutes) conditions
[14]. MTs concentration in the recombinant preparations
was calculated assuming that the only contribution to their
S content was that made by the MT peptides.
2.3. Mass Spectrometry. Molecular mass determination was
performed by electrospray ionization mass spectrometry
equipped with a time-of-ﬂy analyzer (ESI-TOF MS) using
a Micro Tof-Q Instrument (Brucker Daltonics Gmbh, Bre-
men, Germany) calibrated with NaI (200ppm NaI in a
1:1 H 2O:isopropanol mixture), interfaced with a Series
1100 HPLC pump (Agilent Technologies) equipped with
an autosampler, both controlled by the Compass Software.
The experimental conditions for analyzing MT samples
were: 20μL of the sample was injected through a PEEK
long tube (1.5m × 0.18mm i.d.) at 40μL/min under
the following conditions: capillary-counterelectrode voltage,
5.0kV; desolvation temperature, 90–110◦C; dry gas, 6L/min.
Spectra were collected throughout an m/z range from 800
to 2000. The liquid carrier was a 90:10 mixture of 15mM
ammonium acetate and acetonitrile, pH 7.0. All the samples
were injected at least in duplicate to ensure reproducibility.
In all cases, molecular masses were calculated according to
the reported method [15].Bioinorganic Chemistry and Applications 3
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Figure 1: Deconvoluted ESI-TOF MS spectra of the recombinant Zn(II)-MT complexes obtained from the pGEX-MT expression system
with no zinc supplementation to the culture: (a) mouse MT1; (b) yeast Crs5; (c) D. melanogaster MtnB and (d) D. melanogaster MtnA. (e)
MtnB was also synthesized in zinc-enriched medium, to be used as a control.4 Bioinorganic Chemistry and Applications
Table 1: Amino acid sequences of the four MT isoforms analyzed in this work. MtnA and MtnB are two Drosophila melanogaster isoforms.
Crs5 is a Saccharomyces cerevisiae MT and mMT1 is the mouse MT isoform 1. The GST-based expression system used for recombinant
synthesis added two N-terminal residues to these sequences (GS), which was previously shown not to inﬂuence the binding properties of
MT peptides [7], but it has to be considered for the calculation of their theoretical molecular masses (Table 2, Figure 1).
E S C G C A S K K D G G C K C D S G C N C S G K T A Q S A C K C G S G C P C P M MtnA
K N S C C Q D K P G N K C V C Q C D K N C A C N D G C K Q A S C Q C N T G C G K C V M MtnB
  C K E C N C K S K E C T C T T E C K C K E G C S K C Q P S G T S H D C K C K E G G S C S P L C T S G C H C S D K C C E G E C D C I K V T M Crs5
  A C C S C K E S A G K C I C G Q A C K A C S M P C C S C C S K K C S N C K C E K C K C S G T C T C S G G T A C S C N P D M mMT1
3. Results andDiscussion
The four MTs studied in this work (Table 1)c o v e ra
b r o a ds p e c t r u mo fo r g a n i s m s :f r o mv e r t e b r a t e s — t h em o u s e
mMT1 peptide—to invertebrates—two Drosophila (MtnA
andMtnB)peptides—and,unicellulareukaryotes—theyeast
Crs5 MT. Besides, they exhibit diﬀerential metal binding
abilities towards Zn2+ and Cu+, as evidenced by their
position in our Zn- versus Cu-thionein gradated classiﬁ-
cation [9]. The overall results of this study are presented
in a comprehensive table (Table 2) for the sake of easy
comparison, but they are discussed independently below.
One of the MTs, Mtn-B, was also synthesised under excess
zincconditions(300μMintheculturemedium),asapositive
controlinrelationtothenonsupplementedexperiments.Itis
extremely important to highlight that in all cases, the Cd and
Cu content of the preparations was also measured, but the
obtainedvalueswerealwaysnotsigniﬁcant.Thisisconsistent
with the metal ion content reported for the intracellular
environment of E. coli cells, which has been estimated to
be about 0.1mM for zinc while only in the 10-to-100μM
range for copper [16], so Zn2+ ions are indeed the only ones
available for the nascent MT peptides.
The mMT1 isoform, one of the four encoded in the
mouse (mammalian) genomes, has for a long time been
the paradigm of divalent-metal binding MTs. Accordingly,
it is in the third position out of sixteen in our gradate
classiﬁcation of Zn-thioneins, as shown in Table 3. This
means that the corresponding polypeptide has a high ability
to form complexes with divalent metal ions (Zn2+ and
Cd2+) so that these complexes are well folded and remain
steady in physiological conditions. Strikingly, recombinant
synthesis of mMT1 renders unique Zn7-mMT1 complexes
(Figure 1(a),T a b l e2), regardless of whether the bacterial
culture has been supplemented with zinc (300μM) [7]o r
not. This suggests an extreme proﬁciency of mMT1 not only
toformwell-structuredZn-complexeswhenthesemetalions
are in surplus, but also to capture the Zn2+ ions present
in a standard environment, which may be of signiﬁcant
importance when considering its potential functions in
physiological conditions.
Crs5 is a Saccharomyces cerevisiae MT, nonhomologous
to the paradigmatic Cu-thionein Cup1 present in the same
yeast species. Despite initially being considered a secondary
copper-resistance agent, we showed that it determines sur-
vival under zinc overload, and furthermore, all the data
concerning its metal-binding abilities converged to deﬁne
the partial Zn-thionein character of Crs5 [10]. In fact, it
is located in a rather intermediate position in our Zn-
versus Cu-thionein ranking (10th position out of 16 MTs,
Table 3). When this MT is synthesized in the absence of Zn
overload, not only does the mean Zn-per-MT ratio diminish
from 5.7 to 4.2 (Table 2), but there is also a huge variety
of Zn-Crs5 species produced, as revealed by the ESI-MS
spectrum of the sample (Figure 1(b)). Besides the major
Zn4-Crs5 species, the preparation included other complexes,
exhibiting a wide range of stoichiometries, from the highest
value observed under zinc supplementation (Zn7-Crs) to the
major species recovered then [10]( Z n 6-a n dZ n 5-Crs5), as
well as other undermetalated (without metals) complexes,
from Zn3-t oZ n 1-Crs5. It is therefore clear that this MT is
able to coordinate some zinc ions from normal physiological
environments, but in this case, more than half of the
polypeptides encompass a zinc load lower than they would
in excess zinc conditions.
Finally, the two Drosophila MTs, MtnA and MtnB, served
to study the behaviour of Cu-thioneins, since they have
been characterized as the animal MTs that are most similar
to the paradigmatic Cup1 Cu-thionein [9]. Consequently
both polypeptides have been able to render homonuclear
Cu(I)-complexes upon recombinant synthesis in copper-
supplemented media [11, 12]. Despite these properties, Cu-
thioneins are able to fold into Zn2+-containing complexes
when produced under excess zinc as observed in the control
experiment (Figure 1(e),T a b l e2) and literature data [11,
12]. However, our current results provide evidence that
this is not the case in nonsupplemented media, since both
MtnA and MtnB are recovered mostly as apo-forms or Zn1-
Mtn complexes (Table 2). MS spectra of these preparations
(Figures 1(c) and 1(d)) reveal that both MT polypeptides
are severely undermetalated (without metals), with a high
abundance of complexes exhibiting a metal content far
below that they can attain as fully loaded species (Table 3).
Therefore, it has to be assumed that should these MTs be
present in a normal environment (i.e., with no metal ion
surplus), they would coordinate very few Zn2+ ions, if any.
The joint observation of these results leads to important
considerations. First, it is obvious that the levels of Zn(II)
concentrations normally present in the cell cytoplasm (esti-
mated in 0.1mM for E. coli [16]) enable the building of
Zn-MT complexes, even in the absence of zinc overload.
This is extremely important for predicting the fate of the
native MT peptides translated in uninduced conditions, and
itwouldbeinfullagreementwiththehypothesisthatinbasalBioinorganic Chemistry and Applications 5
Table 2: Metal-to-protein ratios and molecular masses of the recombinant Zn(II)-MT, complexes obtained from the pGEX expression
system with no metal supplementation to the culture, except in the Zn-MtnB used as a control (see Section 2). All the measurements have
been performed at least twice, from independently obtained samples.
MT protein Zn/MT(a) Zn/MT(a) Zn-MT species(b)
mexp
(c) mth
(d)
(ICP-AES) (acidic ICP-AES) (ESI-MS)
mMT1 6.95 7.40 Zn7-mMT1 6605.5 6605.96
Crs5 4.20 4.61
Zn4-Crs5 7715.5 7718.92
Zn3-Crs5 · Zn5-Crs5 7654.5 · 7780.5 7655.53 · 7782.31
Zn2-Crs5 · Zn6-Crs5 7590.4 · 7844.5 7592.13 · 7845.70
Zn1-Crs5 · Zn7-Crs5 7525.0 · 7907.5 7528.75 · 7909.09
MtnB 2.04 2.40
apo-MtnB 4667.2 4669.34
Zn1-MtnB 4733.8 4732.73
Zn3-MtnB 4857.0 4859.51
Zn2-MtnB 4795.0 4796.12
Zn4-MtnB 4920.8 4922.9
MtnA 1.70 1.94
apo-MtnA ·Zn1-MtnA 3996.4 · 4059.4 3997.49 · 4060.88
Zn2-MtnA 4121.2 4124.27
Zn3-MtnA 4186.4 4187.66
Zn-MtnB(e) 3.95 5.10 Zn4-MtnB 4922.0 4922.90
Zn3-MtnB 4850.2 4859.51
ICP-AES inductively coupled plasma atomic emission spectroscopy, ESI-MS electrospray ionization mass spectrometry.
(a)In all experiments Cd and Cu contents were also measured but their amount was always under detection limits.
(b)Species proposed according to the mass diﬀerence between holo-protein and apo-protein. Species in bold are the major components of the preparation.
(c)Experimental molecular masses. Measurements were always performed in duplicate. All corresponding standard deviations were always less than 1%.
(d)Theoretical molecular mass of the corresponding species.
(e)Control experiment: MtnB synthesized in Zn(II)-supplemented medium.
Table 3: Comparison of the Zn-MT complexes recovered from recombinant syntheses in Zn- and nonsupplemented culture media.
MT protein
Zn-MT species
recovered when
synthesized in
Zn-supplemented
media
Zn-MT species recovered
when synthesized in
nonsupplemented
media(a)
Mean Zn:MT molar
ratio, when
synthesized in
Zn-supplemented
media
Mean Zn:MT molar
ratio, when
synthesized in
nonsupplemented
media(b)
S i t u a t i o ni nt h e
Zn-/Cu-thionein
gradation(c)
mMT1 Zn7-mMT1 [7]Z n 7-mMT1 7.3 [7]6 . 9 53 / 1 6
Crs5 Zn6-Crs5 · Zn5-Crs5
[10] Zn4-Crs5 5.7 [10] 4.20 10/16
MtnA Zn4-MtnA [11]A p o - M t n A · Zn1-MtnA 3.5 [11] 1.70 14/16
MtnB Zn4-MtnB [12]A p o - M t n B 3 . 7 [ 12] 2.04 15/16
(a)In this work, only major species identiﬁed by ESI-MS are indicated.
(b)In this work, the mean Zn:MT value corresponding to the conventional ICP-AES value is indicated.
(c)The study in [9] includes 16 MT isoforms, classiﬁed from the most extreme Zn-thionein to the most extreme Cu-thionein character.
conditions, MTs exhibiting a clear Zn-thionein character are
synthesized inside cells as Zn2+-complexes, which undergo
the corresponding exchange reaction in the presence of
an excess of other metal ions [17]. However, the Zn-MT
species yielded by the synthesis in nonsupplemented media,
and their relation with those obtained from conventional
zinc-supplemented cultures, are highly dependent on the
type of MT considered, and precisely, on its Zn-thionein
character. Hence, the mouse MT1 isoform, a genuine Zn-
thionein, yields exactly the same result in both culture
conditions, showing its extreme ability to capture Zn2+ ions
from its physiological environment. On the other hand,
the genuine Cu-thioneins analyzed are almost unable to
yield Zn2+-containing complexes unless they are synthesized
under excess zinc, even rendering apo-forms or Zn1-MT as
major products (cf. results for MtnA and MtnB, Figure 1,
Table 2). Comparison of the synthesis in normal and zinc-
enriched media (Table 3), both regarding the mean Zn:MT
content ratio and the Zn2+-containing species recovered,
highlights that the higher the Zn-thionein character of a
MT peptide, the more similar will be the results of the
synthesis of Zn-MT complexes in both conditions. And, on
the contrary, the greater the Cu-thionein character, the more
diﬀerent will be the species resulting from these syntheses,
to the point that Cu-thioneins are characterized by an
inherent incapacity to coordinate Zn2+ ions when present at
physiological concentrations. This means that Cu-thioneins,
if synthesized as the result of the constitutive expression of6 Bioinorganic Chemistry and Applications
their genes (i.e., under no metal surplus), would remain
mainly as apo-peptides inside cells, but never as basal Zn2+-
containing complexes.
4. Conclusion
Comprehensive consideration of our data suggests that
the result of synthesizing diﬀerent MTs in nonmetal-
supplemented media is highly dependent on their Zn- versus
Cu-thioneincharacter.AlthoughinallcasesZn2+-containing
complexes are produced, the former practically yields the
same Zn-MT species when recombinantly produced in zinc-
supplemented and in normal (nonsupplemented) medium,
while the latter is almost unable to coordinate Zn2+ unless
these metal ions are in clear surplus (300μMi nc u l t u r e
media). These results may reﬂect an intrinsically diﬀerent
role of these two types of MTs in physiological conditions,
as well as their well-assumed diﬀerent role when they
are natively synthesized as a protective response to the
corresponding cognate-metal overload.
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